Announced
ThinkEquity and Roth Capital Partners to acquire a stake in Ampio Pharmaceuticals for $50m.
Financials
Transaction Value£42m
Consideration TypeOrdinary Shares
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-
Sources
Tags
Pharmaceuticals
Single Bidder
Public
Acquisition
Friendly
biopharmaceuticals
Pending
United States
Private Equity
Synopsis
ThinkEquity, a boutique investment bank, and Roth Capital Partners, a small privately held investment banking company, agreed to acquire a stake in Ampio Pharmaceuticals, a development-stage biopharmaceutical company, for $50m.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.